MedTrace Logo

Optimal Insertion Time During Remimazolam-Remifentanil Anesthesia for Painless Gastroscopy

NCT07471893 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 342

Last updated 2026-03-13

No results posted yet for this study

Summary

This is a prospective clinical study to compare the anesthetic effect of remimazolam combined with remifentanil administered at different time points during gastroscope insertion in patients undergoing painless gastroscopy.The primary outcomes include sedation effect, intraoperative hemodynamic stability, recovery time, and adverse events.

Conditions

  • Healthy Volunteers

Interventions

OTHER

Dual criterion (absent jaw reflex + stable heart rate) guided endoscope insertion

Intravenous sedation and analgesia with remimazolam combined with remifentanil. Endoscope insertion is performed when jaw reflex is absent and heart rate is stable.

OTHER

Eyelash reflex guided endoscope insertionn

Intravenous sedation and analgesia with remimazolam combined with remifentanil. Endoscope insertion is performed when eyelash reflex is absent.

Sponsors & Collaborators

  • Huizhou First People's Hospital

    lead OTHER

Principal Investigators

  • Jianhao Zeng, MD · Huizhou First People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-08
Primary Completion
2025-12-08
Completion
2025-12-08

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07471893 on ClinicalTrials.gov